Olympia Compounding Pharmacy dba Olympia SB-5 Papaverine 30 mg/mL Phentolamine 3 mg/mL PGE recall — FDA D-0900-2022
Lack of assurance of sterility.
Browse the newest complete recall records currently stored from FDA enforcement reports and NHTSA vehicle campaigns. “Latest” refers to the newest source-dated record in this database, not the timestamp of our last API check.
The newest recall records with useful source details are listed here.
Lack of assurance of sterility.
Lack of assurance of sterility.
Mislabeling: The active ingredient list on the label does not match the product's actual ingredients Specifically, the label states Octinoxate 7.5% and Oxybenzone 3%, while the product…
Labeling: incorrect or missing lot and/or expiration date. An incorrect expiration date was printed on the product labeling with an expiration date of January 2027, whereas the correct…
Lack of assurance of sterility.
Labeling: Label Mix-up: Bottle labeled as Benzonatate 100 mg capsules contained Benzphetamine 50 mg tablets and a bottle labeled as Benzphetamine 50 mg tablets contained Benzonatate 100 mg…
Lack of assurance of sterility.
Lack of assurance of sterility.
Labeling: Label Mix-up: Bottle labeled as Benzonatate 100 mg capsules contained Benzphetamine 50 mg tablets and a bottle labeled as Benzphetamine 50 mg tablets contained Benzonatate 100 mg…
Lack of assurance of sterility.
Defective Delivery System: customer complaints exceeded respective action limits.
Lack of assurance of sterility.
Ford Motor Company (Ford) is recalling certain 2019-2020 Mustang vehicles equipped with 5.0L engines and manual transmissions. The Powertrain Control Module (PCM) may broadcast an…
General Motors, LLC (GM) is recalling certain 2022 GMC Canyon and Chevrolet Colorado vehicles equipped with a manual passenger seat. The front passenger seat may have a hook attachment that…
Honda (American Honda Motor Co.) is recalling certain 2020 CR-V vehicles. The clip for the absorber inside the fuel tank was not secured properly and may detach, which can cause an…
Failed Dissolution Specifications: Sirolimus Oral Solution recalled due to lot RZ1598 exceeded the specification limit at the 14-month timepoint.
CGMP Deviations: Failure to properly investigate failed microbial testing.
TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.
CGMP Deviations: Failure to properly investigate failed microbial testing.
CGMP Deviations: Failure to properly investigate failed microbial testing.
Microbial Contamination of Non-Sterile Products
Microbial Contamination of Non-Sterile Products
Subpotent drug: Low OOS for menthol content at the three month room temperature.
Failed Dissolution Specifications: Nitrofurantoin Capsules recalled due to dissolution failure at 0-time of the repackaged lot. Drug release results were above specification at 0-time.
Browse recent months with enough recall history for useful comparison.